Logomix

Logomix is pursuing the potentials of Geno-Wiring™ platform to develop novel master cells for cell therapy and to apply it the platform to non-human animals, plants and microbes that have long and complex genomes.

Logomix is a large-scale genome writing startup, engineering mammalian genome for industrial customers. We are currently helping biopharma model novel diseases and identify new drug targets for the rare diseases and neurodegenerative diseases such as Huntington's disease and ALS.